These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33663521)

  • 1. Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model.
    Li W; Li S; Chen IX; Liu Y; Ramjiawan RR; Leung CH; Gerweck LE; Fukumura D; Loeffler JS; Jain RK; Duda DG; Huang P
    Radiat Oncol; 2021 Mar; 16(1):48. PubMed ID: 33663521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
    Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
    Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.
    Wang X; Wang JP; Rao XM; Price JE; Zhou HS; Lachman LB
    Breast Cancer Res; 2005; 7(5):R580-8. PubMed ID: 16168101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
    Song C; Hong BJ; Bok S; Lee CJ; Kim YE; Jeon SR; Wu HG; Lee YS; Cheon GJ; Paeng JC; Carlson DJ; Kim HJ; Ahn GO
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):1022-1031. PubMed ID: 27130790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination against neu reduces breast cancer incidence and metastasis in mice.
    Lachman LB; Rao XM; Kremer RH; Ozpolat B; Kiriakova G; Price JE
    Cancer Gene Ther; 2001 Apr; 8(4):259-68. PubMed ID: 11393278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
    Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
    Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.
    Wadsworth BJ; Cederberg RA; Lee CM; Firmino NS; Franks SE; Pan J; Colpo N; Lin KS; Benard F; Bennewith KL
    Cancer Lett; 2020 Nov; 493():31-40. PubMed ID: 32763272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
    Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
    Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.
    Nguyen-Hoai T; Pham-Duc M; Gries M; Dörken B; Pezzutto A; Westermann J
    Cancer Gene Ther; 2016 Jun; 23(6):162-7. PubMed ID: 27056671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.
    Simone BA; Dan T; Palagani A; Jin L; Han SY; Wright C; Savage JE; Gitman R; Lim MK; Palazzo J; Mehta MP; Simone NL
    Cell Cycle; 2016 Sep; 15(17):2265-74. PubMed ID: 27027731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
    Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors.
    Wang LX; Plautz GE
    Breast Cancer Res Treat; 2012 Jul; 134(1):61-70. PubMed ID: 22173696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
    Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
    Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer.
    Hu C; Liu X; Ran W; Meng J; Zhai Y; Zhang P; Yin Q; Yu H; Zhang Z; Li Y
    Biomaterials; 2017 Nov; 144():60-72. PubMed ID: 28823844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anti-tumor effects by combination of tucatinib and radiation in HER2-overexpressing human cancer cell lines.
    Amrell L; Bär E; Glasow A; Kortmann RD; Seidel C; Patties I
    Cancer Cell Int; 2024 Aug; 24(1):277. PubMed ID: 39107782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu.
    Bergman I; Griffin JA; Gao Y; Whitaker-Dowling P
    Int J Cancer; 2007 Jul; 121(2):425-30. PubMed ID: 17354238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy.
    Kuonen F; Laurent J; Secondini C; Lorusso G; Stehle JC; Rausch T; Faes-Van't Hull E; Bieler G; Alghisi GC; Schwendener R; Andrejevic-Blant S; Mirimanoff RO; Rüegg C
    Clin Cancer Res; 2012 Aug; 18(16):4365-74. PubMed ID: 22711708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.
    Kodumudi KN; Ramamoorthi G; Snyder C; Basu A; Jia Y; Awshah S; Beyer AP; Wiener D; Lam L; Zhang H; Greene MI; Costa RLB; Czerniecki BJ
    Front Immunol; 2019; 10():1939. PubMed ID: 31475002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral heterogeneity impacts the response to anti-neu antibody therapy.
    Song H; Kim TO; Ma SY; Park JH; Choi JH; Kim JH; Kang MS; Bae SK; Kim KH; Kim TH; Seo SK; Choi IW; Song GA; Mortenson ED; Fu YX; Park S
    BMC Cancer; 2014 Sep; 14():647. PubMed ID: 25179116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.